Deficiency of Mouse FHR-1 Homolog, FHR-E, Accelerates Sepsis, and Acute Kidney Injury Through Enhancing the LPS-Induced Alternative Complement Pathway
Alternative complement pathway (AP) plays an important role in the development of sepsis, which is life threatening. Deficiency of factor H-related protein 1 (FHR-1), which is a regulator of AP, has been considered as a susceptible factor for atypical hemolytic uremic syndrome (aHUS) and other types...
Saved in:
Published in | Frontiers in immunology Vol. 11; p. 1123 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
19.06.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Alternative complement pathway (AP) plays an important role in the development of sepsis, which is life threatening. Deficiency of factor H-related protein 1 (FHR-1), which is a regulator of AP, has been considered as a susceptible factor for atypical hemolytic uremic syndrome (aHUS) and other types of nephropathy when an inducer such as infection exists. However, the underlying mechanism of the disease development is largely unknown. There is no report on
gene knockout in any animal infection model and its function
is still unclear. Here, a
knockout mouse was generated for investigating AP in sepsis and sepsis-induced acute kidney injury (AKI). We found that murine FHR-1 homolog (FHR-E) deficiency enhanced lipopolysaccharide (LPS)-induced AP activation both
and
and that
knockout mice exhibited more severe sepsis and AKI in response to LPS challenge. These results indicated that FHR-E deficiency promoted LPS-induced sepsis and AKI through AP over-activation, providing a mouse model for studying AP regulation and sepsis. This study revealed the function of FHR-E
, which may further provide hints to the pathogenesis of FHR-1 deficiency-related diseases by enhancing LPS-induced AP activation. |
---|---|
Bibliography: | Edited by: Philippe Saas, INSERM U1098 Interactions Hôte-Greffon-Tumeur & Ingénierie Cellulaire et Génique, France These authors have contributed equally to this work This article was submitted to Inflammation, a section of the journal Frontiers in Immunology Reviewed by: Pilar Sánchez-Corral, University Hospital La Paz Research Institute (IdiPAZ), Spain; Christine Skerka, Leibniz Institute for Natural Product Research and Infection Biology, Germany |
ISSN: | 1664-3224 1664-3224 |
DOI: | 10.3389/fimmu.2020.01123 |